Skip to content Skip to footer

Research Portal of the TU Dresden

EClinicalMedicine

ISSNs: 2589-5370

Additional searchable ISSN (electronic): 2589-5370

Elsevier, Oxford [u.a.], Netherlands

Scopus rating (2024): CiteScore 17 SJR 3.633 SNIP 2.737

Indexed in DOAJ

Journal

Titles	EClinicalMedicine
ISSNs	2589-5370
Additional searchable ISSN (electronic)	2589-5370
Publisher	Elsevier, Oxford [u.a.]
Country/Territory	Netherlands
ZDB-ID	2946413-4

Keywords

ASJC Scopus subject areas

Medicine (all)

Library keywords

610 Medicine and health

Related content

Research output

Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial

AKITA investigators, Oct 2024, In: EClinicalMedicine. 76, 102830.

Research output: Contribution to journal › Research article › Contributed › peer-review

Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)

Pegoraro, F., Papo, M., Cohen-Aubart, F., Peyronel, F., Lugli, G., Trambusti, I. & Baulier, G. & 30 others, de Menthon, M., Le Scornet, T., Oziol, E., Ferreira-Maldent, N., Hermine, O., Faucher, B., Koschel, D., Straetmans, N., Abisror, N., Terrier, B., Lifermann, F., Razanamahery, J., Allenbach, Y., Keraen, J., Bulifon, S., Hervier, B., Buccoliero, A., Charlotte, F., Monzani, Q., Boussouar, S., Shor, N., Tondo, A., Barete, S., Idbaih, A., Tazi, A., Sieni, E., Amoura, Z., Emile, J.-F., Vaglio, A. & Haroche, J., Jul 2024, In: EClinicalMedicine. 73, 102658.

Research output: Contribution to journal › Research article › Contributed › peer-review

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

EPICOVIDEHA registry, May 2024, In: EClinicalMedicine. 71, 102553.

Research output: Contribution to journal › Research article › Contributed › peer-review

Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program

Wiesenfarth, M., Dorst, J., Brenner, D., Elmas, Z., Parlak, Ö., Uzelac, Z. & Kandler, K. & 38 others, Mayer, K., Weiland, U., Herrmann, C., Schuster, J., Freischmidt, A., Müller, K., Siebert, R., Bachhuber, F., Simak, T., Günther, K., Fröhlich, E., Knehr, A., Regensburger, M., German, A., Petri, S., Grosskreutz, J., Klopstock, T., Reilich, P., Schöberl, F., Hagenacker, T., Weyen, U., Günther, R., Vidovic, M., Jentsch, M., Haarmeier, T., Weydt, P., Valkadinov, I., Hesebeck-Brinckmann, J., Conrad, J., Weishaupt, J. H., Schumann, P., Körtvélyessy, P., Meyer, T., Ruf, W. P., Witzel, S., Senel, M., Tumani, H. & Ludolph, A. C., 15 Feb 2024, In: EClinicalMedicine. 69, 12 p., 102495.

Research output: Contribution to journal › Research article › Contributed › peer-review

Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study)

German S&L Study, Stumpf, J., Trips, E. & Hugo, C., Jan 2024, In: EClinicalMedicine. 67, p. 1-15 15 p., 102381.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (7)